DIA is proud to present a dedicated event that focuses on the integration of project/portfolio management and research and development in the healthcare setting that is objective and driven by practitioners, for practitioners. This conference is tailored for project managers in healthcare product development to provide relevant information to be successful given the current climate. Project managers working in all stages of the healthcare product lifecycle will share their perspectives on managing projects during a pandemic and utilizing lessons learned for resource planning, opportunity costs, and trade-offs. Other discussions will be centered on building resiliency in the workplace, understanding and learning from failures in drug development, and appreciating and utilizing diverse leadership styles to drive projects forward.
The Impact of Project Management in Healthcare Product Development meeting is a neutral platform for project and portfolio knowledge sharing related to healthcare research and development. This meeting will provide an in-depth contemplation of topics specific to healthcare product development and project management needs.
Who should attend?
Professionals and students from industry, academia, and government involved in all phases of the healthcare product lifecycle who are interested in applying new skills and tools to improve program and project execution including:
- Global Project Management and Leadership
- Portfolio and Alliance Management
- Functional Leaders and team members
- Clinical Operations
- Regulatory Affairs Professionals
- Clinical Development
- Discuss the important role that project managers play in managing complexity and enabling execution in healthcare product development
- Describe how COVID-19 changed project management for vaccine, therapeutic, and diagnostic development
- Identify methods of adaptation and lessons learned from managing projects during the COVID-19 pandemic and apply best practices as new standards for healthcare product development
- Apply methodologies and technologies to enhance project planning, learn from past experiences, and effectively lead and collaborate on projects
- Describe the adaptations and methods that project managers used during the pandemic to deliver vaccines, therapeutics, and diagnostics under stress and accelerated timelines
Karla Childers, MS • Bioethics & Strategic Projects Leader, Office of the Chief Medical Officer
Johnson & Johnson, United States
Nita Ichhpurani, PMP • Consultant To Daiichi Sankyo, Inc.
Phase One Forward, Consultant, Canada
Mark Kryah, PMP • Executive Director/Program Team Leader
Leigh Shultz, PhD, PMP • Executive Director, Human Health Commercial Operations
Merck & Co., Inc., United States
Elizabeth Somers, MS • Executive Director of Infectious Disease, Global Project and Alliance Management
Merck Sharp & Dohme LLC, United States